Misplaced Pages

DIDO-2: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 02:16, 8 April 2017 editDan Koehl (talk | contribs)Autopatrolled, Extended confirmed users, Page movers, File movers, Mass message senders, New page reviewers, Pending changes reviewers, Rollbackers40,931 editsm clean up, added uncategorised tag, typo(s) fixed: 4.2 Kg → 4.2 kg using AWB← Previous edit Revision as of 11:05, 8 April 2017 edit undoFirkin Flying Fox (talk | contribs)Extended confirmed users595 edits ReferencesNext edit →
Line 10: Line 10:
{{satellite-stub}} {{satellite-stub}}
{{Uncategorized stub|date=April 2017}} {{Uncategorized stub|date=April 2017}}
]

Revision as of 11:05, 8 April 2017

DIDO-2, also known as Chen Jiayong 1, is a nano-satellite designed by the Swiss company SpacePharma. This is a research project whose goal is to test a miniaturized end-to-end pharmaceutical laboratory in space under micro-gravity conditions. DIDO-2 was successfully launched on February 15, 2017 3:58 UTC on PSLV-C37 on a record-breaking launch which released 104 satellites.

Specifications

DIDO-2 is a 3U CubeSat, weighing 4.2 kg.

References

  1. DIDO 1, 2
  2. ISIS supported CubeSats
  3. Global, IndraStra. "NEWS | India's ISRO Successfully Launched 104 Satellites in a Single Mission". IndraStra. ISSN 2381-3652.
  4. Clark, Stephen (February 15, 2017). "India lofts a record 104 spacecraft on a single rocket". Spaceflight Now.


Stub icon

This spacecraft or satellite related article is a stub. You can help Misplaced Pages by expanding it.

This article has not been added to any content categories. Please help out by adding categories to it so that it can be listed with similar articles, in addition to a stub category. (April 2017)
Categories: